Cindy Maurel

Dr. Cindy Maurel

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 July 2016 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
PRParals Registry
Parals Registry
WRWouter van Rheenen
Wouter van Rheenen
SGSLALOM Group
SLALOM Group
SRSlap Registry
Slap Registry
FCFALS Sequencing Consortium
FALS Sequencing Consortium
JVJan H Veldink
Jan H Veldink

10 January 2018 in Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
CMCindy Maurel
Cindy Maurel
ADA. Dangoumau
A. Dangoumau
SMS. Marouillat
S. Marouillat
CBC. Brulard
C. Brulard
ACAnna Ania CHAMI
Anna Ania CHAMI
Patrick Vourc'hPatrick Vourc'h
Patrick Vourc'h

15 November 2019 in Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
CMCindy Maurel
Cindy Maurel
ACAnna Ania CHAMI
Anna Ania CHAMI
RTRose-Anne Thépault
Rose-Anne Thépault
SMSylviane Marouillat
Sylviane Marouillat
HBHélène Blasco
Hélène Blasco
PVPatrick Vourc’h
Patrick Vourc’h

21 February 2024 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
NSNatalie M Scherer
Natalie M Scherer
CMCindy Maurel
Cindy Maurel
MGMatthew S Graus
Matthew S Graus
LMLuke McAlary
Luke McAlary
GRGrant Richter
Grant Richter
MMMarco Morsch
Marco Morsch
Insoluble cytoplasmic aggregate formation of the RNA-binding protein TDP-43 is a major hallmark of neurodegenerative diseases including Amyotrophic Lateral Sclerosis. TDP-43 localizes predominantly in the nucleus, arranging itself into dynamic condensates through liquid–liquid phase separation (LLPS). Mutations and post-translational modifications can alter the condensation properties of TDP-43, contributing to the transition of liquid-like biomolecular condensates into solid-like aggregates. However, to date it has been a challenge to study the dynamics of this process in vivo. We demonstrate through live imaging that human TDP-43 undergoes nuclear condensation in spinal motor neurons in a living animal. RNA-binding deficiencies as well as post-translational modifications can lead to aberrant condensation and altered TDP-43 compartmentalization. Single-molecule tracking revealed an altered mobility profile for RNA-binding deficient TDP-43. Overall, these results provide a critically needed in vivo characterization of TDP-43 condensation, demonstrate phase separation as an important regulatory mechanism of TDP-43 accessibility, and identify a molecular mechanism of how functional TDP-43 can be regulated.

7 January 2021 in Molecular Neurobiology
Verified
Journal Article
Open access
PDF file
EDEmily K. Don
Emily K. Don
AMAlina Maschirow
Alina Maschirow
RRRowan Radford
Rowan Radford
NSNatalie M. Scherer
Natalie M. Scherer
AVAndrés Vidal-Itriago
Andrés Vidal-Itriago
MMMarco Morsch
Marco Morsch
Amyotrophic lateral sclerosis (ALS) is a form of motor neuron disease (MND) that is characterized by the progressive loss of motor neurons within the spinal cord, brainstem, and motor cortex. Although ALS clinically manifests as a heterogeneous disease, with varying disease onset and survival, a unifying feature is the presence of ubiquitinated cytoplasmic protein inclusion aggregates containing TDP-43. However, the precise mechanisms linking protein inclusions and aggregation to neuronal loss are currently poorly understood. Bimolecular fluorescence complementation (BiFC) takes advantage of the association of fluorophore fragments (non-fluorescent on their own) that are attached to an aggregation-prone protein of interest. Interaction of the proteins of interest allows for the fluorescent reporter protein to fold into its native state and emit a fluorescent signal. Here, we combined the power of BiFC with the advantages of the zebrafish system to validate, optimize, and visualize the formation of ALS-linked aggregates in real time in a vertebrate model. We further provide in vivo validation of the selectivity of this technique and demonstrate reduced spontaneous self-assembly of the non-fluorescent fragments in vivo by introducing a fluorophore mutation. Additionally, we report preliminary findings on the dynamic aggregation of the ALS-linked hallmark proteins Fus and TDP-43 in their corresponding nuclear and cytoplasmic compartments using BiFC. Overall, our data demonstrates the suitability of this BiFC approach to study and characterize ALS-linked aggregate formation in vivo. Importantly, the same principle can be applied in the context of other neurodegenerative diseases and has therefore critical implications to advance our understanding of pathologies that underlie aberrant protein aggregation.

13 July 2017 in Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
Verified
Journal Article
Closed access
CMCindy Maurel
Cindy Maurel
BMBlandine Madji-Hounoum
Blandine Madji-Hounoum
RTRose-Anne Thepault
Rose-Anne Thepault
SMSylviane Marouillat
Sylviane Marouillat
CBCéline Brulard
Céline Brulard
Patrick Vourc'hPatrick Vourc'h
Patrick Vourc'h
Mutations in the TAR-DNA Binding Protein-43 (TDP-43) encoding the TARDBP gene are present in amyotrophic lateral sclerosis (ALS). TDP-43 is the major component of ubiquitin-positive inclusions in motor neurons in ALS patients. We report here a novel heterozygous missense mutation in TARDBP in an ALS patient presenting a rapid form of ALS. This mutation p.N259S is located within the RNA recognition motif 2 (RRM2) in very close proximity with nucleotides in RNA. It is the first time a mutation was reported in this RRM2 domain of TDP-43. Expression of TDP-43N259S in neuronal cells NSC-34 and in primary cultures of motor neurons was associated with cytoplasmic TDP-43/ubiquitin positive inclusions. Our findings identified for the first time a mutation in ALS in the RRM2 domain of TDP-43, reinforcing the link between this RNA-binding protein, perturbations in RNA metabolism, disruption in protein homeostasis and ALS.